Clinical perspectives from the BEGIN and EDITION programmes: Trial-level meta-analyses outcomes with either degludec or glargine 300 U/mL vs glargine 100 U/mL in T2DM
| Autor: | Roussel, R., Ritzel, R., Boëlle-Le Corfec, E., Balkau, B., Rosenstock, J. |
|---|---|
| Zdroj: | In Diabetes and Metabolism November 2018 44(5):402-409 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect